MA41957A - Conjugués d'une fraction d'il-7 et d'un polymère - Google Patents
Conjugués d'une fraction d'il-7 et d'un polymèreInfo
- Publication number
- MA41957A MA41957A MA041957A MA41957A MA41957A MA 41957 A MA41957 A MA 41957A MA 041957 A MA041957 A MA 041957A MA 41957 A MA41957 A MA 41957A MA 41957 A MA41957 A MA 41957A
- Authority
- MA
- Morocco
- Prior art keywords
- conjugates
- fraction
- polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2046—IL-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5418—IL-7
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562131634P | 2015-03-11 | 2015-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA41957A true MA41957A (fr) | 2018-02-28 |
Family
ID=56878892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA041957A MA41957A (fr) | 2015-03-11 | 2016-03-11 | Conjugués d'une fraction d'il-7 et d'un polymère |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190290733A1 (fr) |
| EP (1) | EP3285799A4 (fr) |
| JP (3) | JP2018510863A (fr) |
| KR (1) | KR20170125839A (fr) |
| CN (1) | CN107405384A (fr) |
| AU (1) | AU2016228555B2 (fr) |
| CA (1) | CA2978330C (fr) |
| IL (1) | IL254389B2 (fr) |
| MA (1) | MA41957A (fr) |
| MX (1) | MX2017011562A (fr) |
| WO (1) | WO2016145388A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002026265A2 (fr) | 2000-09-29 | 2002-04-04 | Schering Corporation | Interleukine 10 pegylee |
| AU2007314501B2 (en) | 2006-09-28 | 2013-05-23 | Merck Sharp & Dohme Corp. | Use of pegylated IL-10 to treat cancer |
| CN106913865A (zh) | 2013-04-18 | 2017-07-04 | 阿尔莫生物科技股份有限公司 | 使用白细胞介素‑10治疗疾病和病症的方法 |
| EP3010527B1 (fr) | 2013-06-17 | 2018-08-08 | Armo Biosciences, Inc. | Méthode d'évaluation de l'identité et de la stabilité d'une protéine |
| RU2016122957A (ru) | 2013-11-11 | 2017-12-19 | Армо Байосайенсиз, Инк. | Способы применения интерлейкина-10 для лечения заболеваний и расстройств |
| WO2015187295A2 (fr) | 2014-06-02 | 2015-12-10 | Armo Biosciences, Inc. | Méthodes permettant de faire baisser le cholestérol sérique |
| KR20170084033A (ko) | 2014-10-22 | 2017-07-19 | 아르모 바이오사이언시스 인코포레이티드 | 질환 및 장애를 치료하기 위해 인터루킨-10을 사용하는 방법 |
| WO2016126615A1 (fr) | 2015-02-03 | 2016-08-11 | Armo Biosciences, Inc. | Procédés d'utilisation de l'interleukine-10 pour le traitement de maladies et de troubles |
| WO2016191587A1 (fr) | 2015-05-28 | 2016-12-01 | Armo Biosciences, Inc. | Interleukine 10 pégylée utilisée pour le traitement du cancer |
| WO2017035232A1 (fr) | 2015-08-25 | 2017-03-02 | Armo Biosciences, Inc. | Procédés d'utilisation de l'interleukine-10 pour le traitement de maladies et de troubles |
| WO2020121071A1 (fr) * | 2018-12-12 | 2020-06-18 | Levim Biotech Llp | Procédé d'acylation pour la préparation de peptide n-substitué |
| WO2022020637A1 (fr) * | 2020-07-22 | 2022-01-27 | Nektar Therapeutics | Composition d'agonistes du récepteur il-7, et méthodes et utilisations associées |
| WO2023133595A2 (fr) | 2022-01-10 | 2023-07-13 | Sana Biotechnology, Inc. | Méthodes de dosage et d'administration ex vivo de particules lipidiques ou de vecteurs viraux ainsi que systèmes et utilisations associés |
| WO2023193015A1 (fr) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Polythérapies d'agoniste de récepteur de cytokine et de vecteur viral |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7666400B2 (en) * | 2005-04-06 | 2010-02-23 | Ibc Pharmaceuticals, Inc. | PEGylation by the dock and lock (DNL) technique |
| AU2002307497A1 (en) * | 2001-04-23 | 2002-11-05 | The Regents Of The University Of California | Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts |
| PL374354A1 (en) * | 2001-11-20 | 2005-10-17 | Pharmacia Corporation | Chemically-modified human growth hormone conjugates |
| EP1391513A1 (fr) * | 2002-08-08 | 2004-02-25 | Cytheris | Substance médicamenteuse IL-7, composition comprenant IL-7, procédé de sa préparation et ses utilisations |
| TWI364295B (en) * | 2002-12-26 | 2012-05-21 | Mountain View Pharmaceuticals | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| ES2342964T3 (es) * | 2004-12-09 | 2010-07-20 | Merck Patent Gmbh | Variantes de la interleucina-7 con inmunogenicidad reducida. |
| JP5647899B2 (ja) * | 2008-01-08 | 2015-01-07 | ラツィオファルム ゲーエムベーハーｒａｔｉｏｐｈａｒｍ ＧｍｂＨ | オリゴサッカリルトランスフェラーゼを使用するポリペプチドの複合糖質化 |
| CA3144697A1 (fr) * | 2010-11-12 | 2012-05-18 | Nektar Therapeutics | Conjugues d'une fraction il-2 et d'un polymere |
| CN102145178B (zh) * | 2011-04-15 | 2012-09-26 | 北京凯因科技股份有限公司 | Peg化白介素15 |
| WO2013020079A2 (fr) * | 2011-08-04 | 2013-02-07 | Nektar Therapeutics | Conjugués d'une fraction il-11 et d'un polymère |
| US9375465B2 (en) * | 2011-11-14 | 2016-06-28 | Emory University | Conjugates of GM-CSF and IL-7, compositions and methods related thereto |
-
2016
- 2016-03-11 WO PCT/US2016/022146 patent/WO2016145388A1/fr active Application Filing
- 2016-03-11 KR KR1020177024937A patent/KR20170125839A/ko not_active Application Discontinuation
- 2016-03-11 MA MA041957A patent/MA41957A/fr unknown
- 2016-03-11 IL IL254389A patent/IL254389B2/en unknown
- 2016-03-11 JP JP2017547157A patent/JP2018510863A/ja not_active Withdrawn
- 2016-03-11 CA CA2978330A patent/CA2978330C/fr active Active
- 2016-03-11 MX MX2017011562A patent/MX2017011562A/es unknown
- 2016-03-11 EP EP16762659.7A patent/EP3285799A4/fr active Pending
- 2016-03-11 CN CN201680014816.7A patent/CN107405384A/zh active Pending
- 2016-03-11 US US15/556,996 patent/US20190290733A1/en active Pending
- 2016-03-11 AU AU2016228555A patent/AU2016228555B2/en active Active
-
2021
- 2021-03-01 JP JP2021031726A patent/JP2021091708A/ja active Pending
-
2022
- 2022-08-16 JP JP2022129624A patent/JP2022163194A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3285799A4 (fr) | 2018-08-08 |
| MX2017011562A (es) | 2018-05-11 |
| WO2016145388A1 (fr) | 2016-09-15 |
| CA2978330A1 (fr) | 2016-09-15 |
| JP2018510863A (ja) | 2018-04-19 |
| JP2022163194A (ja) | 2022-10-25 |
| AU2016228555A1 (en) | 2017-08-31 |
| AU2016228555B2 (en) | 2021-12-23 |
| EP3285799A1 (fr) | 2018-02-28 |
| IL254389A0 (en) | 2017-11-30 |
| IL254389B2 (en) | 2023-03-01 |
| KR20170125839A (ko) | 2017-11-15 |
| US20190290733A1 (en) | 2019-09-26 |
| JP2021091708A (ja) | 2021-06-17 |
| IL254389B (en) | 2022-11-01 |
| CN107405384A (zh) | 2017-11-28 |
| CA2978330C (fr) | 2024-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA41957A (fr) | Conjugués d'une fraction d'il-7 et d'un polymère | |
| MA49715A (fr) | Oligomères et conjugués d'oligomères | |
| DK3592393T3 (da) | Frigørbare konjugater | |
| BR112017008404A2 (pt) | seringa com auto-orientação e interface se seringa | |
| DK3155024T3 (da) | Opholdsstrukturer og relaterede fremgangsmåder | |
| MA40933A (fr) | Difluorométhyl-aminopyridines et difluorométhyl-aminopyrimidines | |
| FR3016945B1 (fr) | Plaque d'amortissement | |
| FR3019522B1 (fr) | Ensemble sustentateur amovible d'un giravion et giravion | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| BR112016003413A2 (pt) | prancha ergometrica de uma esteira ergometrica e esteira ergometrica | |
| FR3033706B3 (fr) | Simulateur d'escalier | |
| FI20146023A (fi) | Hammas- ja kielituki | |
| MA49905A (fr) | Polyesteramines et polyesterquats | |
| FR3033708B3 (fr) | Simulateur d'escalier | |
| MA43873A (fr) | Dspositif d'injection | |
| DK3544634T3 (da) | MET-antistof-lægemiddelkonjugater | |
| DK3018383T3 (da) | Afslutning af styrkeelementer i dybhavskabler | |
| MA42954A (fr) | Potentialisateurs cftr deutérés | |
| DE202014105547U8 (de) | Steckverbinder und Steckverbindung | |
| FI20160028A (fi) | Tolpan perustus | |
| MA45326A (fr) | Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation | |
| DK3176187T4 (da) | Hærdbar polymersammensætning | |
| DK3099314T3 (da) | Tolerogene sammensætninger og anvendelser deraf | |
| FR3027500B1 (fr) | Meuble d'exposition | |
| UA36873S (uk) | Спортивний майданчик |